XML 17 R2.htm IDEA: XBRL DOCUMENT v3.24.1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2023
Dec. 31, 2022
Current assets:    
Cash and cash equivalents $ 14,025 $ 14,365
Accounts receivable, net 1,906 3,788
Contract assets 1,604 2,170
Inventories, net 4,454 2,538
Other current assets 852 797
Total current assets 22,841 23,658
Employee retention credit receivable 1,529
Property, plant and equipment, net 12,166 12,596
Intangible assets, net 9 119
Other assets 9 10
Total assets 35,025 37,912
Current liabilities:    
Accounts payable 1,203 1,454
Accrued expenses 1,765 2,591
Current maturities of long-term debt 81 77
Deposits from purchasers of MesoScribe assets – note 15 597
Contract liabilities 4,908 4,042
Total current liabilities 8,554 8,164
Long-term debt, net of current portion 268 349
Total liabilities 8,822 8,513
Commitments and contingencies (see note 13)
Stockholders’ equity:    
Common stock - $0.01 par value – 20,000,000 shares authorized; issued and outstanding 6,824,511 at December 31, 2023 and 6,760,938 at December 31, 2022 68 67
Additional paid-in capital 28,695 27,712
(Accumulated deficit) retained earnings (2,560) 1,620
Total stockholders’ equity 26,203 29,399
Total liabilities and stockholders’ equity $ 35,025 $ 37,912